The report covers the sustainable development direction, strategy and performance of CANbridge Pharmaceuticals Inc., outlining strategies implemented and summarizes the performance for the year, with a view to elaborate on the efforts the company upholds and the long-term value it creates for its stakeholders. The report outlines the company's material ESG issues, and discusses its ESG performance in the areas of environmental compliance, emissions, water use, waste management, human resources practices, staff training, supplier management, product safety, community investment, data privacy, and anti-corruption.
Issuing Company Canbridge Pharmaceuticals Inc.
Report Type Sustainability Report
Report Language EN
Report Filesize 8.66 MB
No. of Pages 36 pages
Reporting periodJanuary 1, 2022-December 31, 2022
Report Edition2
Assurance Provider Unknown
Reporting Standards GRI; SASB; UNSDGs
Materiality Assessmenttrue
